Data / Drug companies / l-Thyroxine
l-Thyroxine drugs: 7 drugs from 59 companies in the FDA NDC directory
l-Thyroxine is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 656 products in this class from 59 companies, covering 7 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 31, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 59Companies
- 656Products
- 7Drugs by generic name
Drugs in the l-Thyroxine class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Levothyroxine sodium | 565 | 44 |
| Levothyroxine, liothyronine | 24 | 9 |
| Levothyroxine sodium anhydrous | 19 | 6 |
| Levothyroxine and liothyronine | 15 | 2 |
| Thyroid tablets | 15 | 1 |
| Levothyroxine liothyronine | 1 | 1 |
| Levothyroxinum | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 77 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Bryant Ranch Prepack | 47 | tablet | Generic drugs (ANDA) | December 21, 2022 |
| Northwind Health Company, LLC | 36 | tablet | Generic drugs (ANDA) | March 30, 2023 |
| Ibsa Pharma Inc. | 30 | capsule; solution | New drug applications (NDA) | March 1, 2023 |
| Preferred Pharmaceuticals Inc. | 28 | tablet | Generic drugs (ANDA) | April 20, 2026 |
| NuCare Pharmaceuticals,Inc. | 20 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Proficient Rx LP | 17 | tablet | New drug applications (NDA) | December 10, 2020 |
| Calvin Scott & Co., Inc. | 15 | tablet | Other unapproved drugs | August 1, 2025 |
| Direct_Rx | 15 | tablet | New drug applications (NDA) | January 9, 2025 |
| Alvogen Inc. | 14 | tablet | New drug applications (NDA) | May 7, 2019 |
| Proficient Rx LP | 14 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Cardinal Health 107, LLC | 13 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Coupler LLC | 13 | tablet | Generic drugs (ANDA) | July 6, 2026 |
| Remedyrepack Inc. | 13 | tablet | Generic drugs (ANDA) | August 13, 2025 |
| AbbVie Inc. | 12 | tablet | New drug applications (NDA) | July 24, 2002 |
| Accord Healthcare Inc. | 12 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Amneal Pharmaceuticals LLC | 12 | tablet | New drug applications (NDA) | July 3, 2014 |
| Amneal Pharmaceuticals NY LLC | 12 | tablet | Authorized generics (NDA) | October 1, 2007 |
| Asclemed USA Inc. | 12 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Camber Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | January 18, 2023 |
| Lannett Company, Inc. | 12 | tablet | Authorized generics (NDA) | August 3, 2020 |
| Lupin Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Macleods Pharmaceuticals Limited | 12 | tablet | Generic drugs (ANDA) | December 21, 2022 |
| XLCare Pharmaceuticals, Inc. | 12 | tablet | Generic drugs (ANDA) | January 18, 2023 |
| Yaral Pharma Inc. | 12 | capsule | Authorized generics (NDA) | March 1, 2023 |
| American Health Packaging | 11 | tablet | Generic drugs (ANDA) | January 5, 2021 |
| Fresenius Kabi USA, LLC | 11 | injection, powder, lyophilized, for solution; injection, solution | New drug applications (NDA) | May 29, 2018 |
| NorthStar RxLLC | 11 | tablet | Generic drugs (ANDA) | April 8, 2025 |
| Pfizer Laboratories Div Pfizer Inc | 11 | tablet | New drug applications (NDA) | May 25, 2001 |
| Bryant Ranch Prepack | 10 | tablet | Authorized generics (NDA) | August 3, 2020 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 10 | tablet | New drug applications (NDA) | October 1, 2007 |
| Bryant Ranch Prepack | 9 | tablet | Authorized generics (NDA) | August 3, 2020 |
| Major Pharmaceuticals | 9 | tablet | Generic drugs (ANDA) | May 2, 2019 |
| Genus Lifesciences | 8 | tablet | Other unapproved drugs | March 1, 2025 |
| Energique, Inc. | 7 | liquid | Unapproved homeopathic products | February 18, 2026 |
| Trifluent Pharma, LLC | 7 | tablet | Other unapproved drugs | October 12, 2025 |
| Acella Pharmaceuticals, LLC | 6 | tablet | Other unapproved drugs | October 31, 2026 |
| Mylan Institutional Inc. | 6 | tablet | Generic drugs (ANDA) | February 26, 2007 |
| Apex Energetics Inc. | 5 | solution/ drops | Unapproved homeopathic products | March 22, 2022 |
| Asclemed USA, Inc. | 5 | tablet | Other unapproved drugs | June 12, 2017 |
| Aurobindo Pharma Limited | 5 | tablet | Generic drugs (ANDA) | July 16, 2024 |
| Teva Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | September 21, 2022 |
| Mylan Institutional Inc. | 4 | tablet | Generic drugs (ANDA) | January 14, 2019 |
| Guna Spa | 3 | solution/ drops | Unapproved homeopathic products | September 24, 2020 |
| Maia Pharmaceuticals, Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 27, 2018 |
| Onesource Specialty Pharma Limited | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 27, 2026 |
| Par Health USA, LLC | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | June 24, 2011 |
| Redpharm Drug | 3 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Sagent Pharmaceuticals | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 1, 2024 |
| Zydus Pharmaceuticals USA Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Piramal Critical Care Inc | 2 | injection | Generic drugs (ANDA) | October 1, 2022 |
| BioActive Nutritional, Inc. | 1 | liquid | Unapproved homeopathic products | July 29, 2021 |
| Fosun Pharma USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 16, 2025 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | New drug applications (NDA) | November 15, 2022 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | July 5, 2023 |
| Oliva Therapeutics, LLC | 1 | solution | New drug applications (NDA) | July 1, 2025 |
| The Wellness Center for Research and Education, Inc. | 1 | liquid | Unapproved homeopathic products | June 3, 2020 |
| Zydus Lifesciences Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 1, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 565 | 86.1% |
| Capsule | 27 | 4.1% |
| Injection, powder, lyophilized, for solution | 23 | 3.5% |
| Solution | 16 | 2.4% |
| Liquid | 9 | 1.4% |
| Solution/ drops | 8 | 1.2% |
| Injection, solution | 6 | 0.9% |
| Injection | 2 | 0.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.